Details of the Drug Reposition

General Information of This Drug (ID: DMXI8X0)

Drug Name
Mitapivat   DMXI8X0
Synonyms AG-348
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hereditary haemolytic anemia DIS487SI 3A10.3 Approved [1]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pyruvate kinase deficiency DIS3LZ44 5C53.00 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 216196.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)